SPRYCEL
- Dasatinib - @- Protein Tyrosine Kinase Inhibitors - Antineoplastic Agents- (Aug 2006)
Compositions:
Dasatinib 20mg/50mg/70mg tablets,
List of Related Indications:
Dasatinib 20mg/50mg/70mg tablets,
- Chronic lymphocytic leukemia -CLL
Strength | Rate | Packing Style |
---|---|---|
20mg | 82820.00 | 60s tablets |
50mg | 197238.00 | 60s tablets |
70mg | 190585.00 | 60s tablets |